{"disease":{"id":"weight","name":"weight"},"drugs":{"marketed":[{"drug_id":"semaglutide","indication_name":"Weight loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ozempic","generic_name":"semaglutide","company_name":"Novo Nordisk","drug_phase":"marketed","molecular_target":"GLP-1 receptor","drug_class":"GLP-1 Receptor Agonist [EPC]","quality_score":90,"revenue":"27400","mechanism":"Semaglutide, a GLP-1 analogue, lowers blood glucose by stimulating insulin and inhibiting glucagon secretion in a glucose-dependent manner, and delays gastric emptying."},{"drug_id":"liraglutide","indication_name":"Weight loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Victoza","generic_name":"liraglutide","company_name":"Novo Nordisk","drug_phase":"marketed","molecular_target":"Glucagon-like peptide 1 receptor","drug_class":"GLP-1 Receptor Agonist [EPC]","quality_score":35,"revenue":"3200","mechanism":null},{"drug_id":"glutamic-acid","indication_name":"Prevent Nitrogen and Weight Loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Glutamate","generic_name":"GLUTAMIC ACID","company_name":"","drug_phase":"marketed","molecular_target":"Glutamate dehydrogenase 1, mitochondrial, Glutamate dehydrogenase 2, mitochondrial, Metabotropic glutamate receptor 6","drug_class":"Amino Acid [EPC]","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"histidine","indication_name":"Prevent Nitrogen and Weight Loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"L-Histidine","generic_name":"HISTIDINE","company_name":"","drug_phase":"marketed","molecular_target":"Large neutral amino acids transporter small subunit 1","drug_class":"Amino Acid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chlorella","indication_name":"Difficulty losing weight","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Chlorella","company_name":"Cardinal Tien Hospital","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":10,"revenue":null,"mechanism":null},{"drug_id":"phentermine-and-topiramate","indication_name":"Overweight with Comorbidity Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Phentermine and Topiramate","company_name":"VIVUS LLC","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":40,"revenue":null,"mechanism":"Phentermine and topiramate reduce appetite and food consumption through different mechanisms involving catecholamine release and neurotransmitter modulation."},{"drug_id":"pyrilamine","indication_name":"Water Weight Gain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PYRILAMINE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Central Nervous System Stimulant [EPC]","quality_score":10,"revenue":null,"mechanism":null},{"drug_id":"dronabinol","indication_name":"Anorexia associated with weight loss in AIDS","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Marinol","generic_name":"DRONABINOL","company_name":"Wellhouse Pharma","drug_phase":"marketed","molecular_target":"Cannabinoid receptors","drug_class":"Cannabinoid [EPC]","quality_score":80,"revenue":null,"mechanism":"Dronabinol acts on cannabinoid receptors in the CNS, potentially through central sympathomimetic activity."},{"drug_id":"phendimetrazine-tartrate","indication_name":"Short-term weight management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PHENDIMETRAZINE TARTRATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"phendimetrazine-tartrate","indication_name":"Short-term weight management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PHENDIMETRAZINE TARTRATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"pyrilamine-maleate","indication_name":"Water Weight Gain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PYRILAMINE MALEATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Central Nervous System Stimulant [EPC]","quality_score":10,"revenue":null,"mechanism":null},{"drug_id":"ferulic-acid","indication_name":"Chronic weight management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ferulic Acid","company_name":"Salah Awad Alanazi","drug_phase":"marketed","molecular_target":"","drug_class":"Non-Standardized Chemical Allergen [EPC]","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"pentorex","indication_name":"Weight loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Phenpentermine","generic_name":"PENTOREX","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"pentorex","quality_score":null,"revenue":null,"mechanism":"Phenpentermine works by increasing the levels of certain neurotransmitters in the brain that help regulate appetite and metabolism."},{"drug_id":"lopid","indication_name":"Reducing risk of developing coronary heart disease in Type IIb patients without history or symptoms of existing coronary heart disease with low HDL-cholesterol, elevated LDL-cholesterol, and elevated triglycerides unresponsive to weight loss, diet, exercise, and other pharmacologic agents","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lopid","generic_name":"Gemfibrozil","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"PPAR-alpha (Peroxisome Proliferator-Activated Receptor Alpha)","drug_class":"Peroxisome Proliferator Receptor alpha Agonist [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"pf-06954522","indication_name":"Spinal Muscular Atrophy (SMA) with a genetically confirmed diagnosis of SMA type 1, or SMA type 2 or 3 in patients with a body weight of 13 kg or less","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pf-06954522","generic_name":"pf-06954522","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"[specific target]","drug_class":"Small molecule inhibitor","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"liraglutid","indication_name":"Weight loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Liraglutid","company_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","drug_phase":"marketed","molecular_target":"Glucagon-like peptide 1 receptor","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"saxenda","indication_name":"Weight loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Saxenda","company_name":"Seoul National University Hospital","drug_phase":"marketed","molecular_target":"Glucagon-like peptide 1 receptor","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"victoza","indication_name":"Weight loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Victoza","company_name":"Hanmi Pharmaceutical Company Limited","drug_phase":"marketed","molecular_target":"Glucagon-like peptide 1 receptor","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"aminorex","indication_name":"Weight loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Apiquel","generic_name":"AMINOREX","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"aminorex","quality_score":13,"revenue":null,"mechanism":""},{"drug_id":"alanine","indication_name":"Prevent Nitrogen and Weight Loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"L-Alanine","generic_name":"ALANINE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Amino Acid [EPC]","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"rybelsus","indication_name":"Weight loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rybelsus","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Glucagon-like peptide 1 receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"diuretic","indication_name":"Weight gain relief","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Diuretic","company_name":"Reprieve Cardiovascular, Inc","drug_phase":"marketed","molecular_target":"","drug_class":"Calculi Dissolution Agent [EPC]","quality_score":16,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":22,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06275061","title":"Chinese Obesity and MEtabolic Surgery Database (COMES Database)","phase":"","overall_status":"RECRUITING","enrollment_count":1000000,"lead_sponsor_name":"Jinan University Guangzhou","has_results":false},{"nct_id":"NCT04614961","title":"Database Concerning Patients Consulting the Obesity Clinic","phase":"","overall_status":"RECRUITING","enrollment_count":999999,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT07096063","title":"Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular Risk","phase":"","overall_status":"COMPLETED","enrollment_count":887132,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT07358052","title":"Current Status of Cardiovascular Diseases in Chinese Overweight/ Obesity Population: An Epidemiological Study (COPE）","phase":"","overall_status":"COMPLETED","enrollment_count":551931,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT07465926","title":"Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3","phase":"","overall_status":"COMPLETED","enrollment_count":451036,"lead_sponsor_name":"Chung Shan Medical University","has_results":false},{"nct_id":"NCT07141914","title":"A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real World","phase":"","overall_status":"COMPLETED","enrollment_count":285327,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT05810545","title":"Drinking Water PFAS, Pregnancy Outcome and Maternal Morbidity","phase":"","overall_status":"COMPLETED","enrollment_count":256659,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT03330301","title":"D-tecting Disease - From Exposure to Vitamin D During Critical Periods of Life","phase":"","overall_status":"COMPLETED","enrollment_count":222776,"lead_sponsor_name":"Bispebjerg Hospital","has_results":false},{"nct_id":"NCT07513259","title":"Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes","phase":"","overall_status":"COMPLETED","enrollment_count":203424,"lead_sponsor_name":"Chung Shan Medical University","has_results":false},{"nct_id":"NCT03112018","title":"Strengthening Facility-based Intrapartum/Immediate Newborn Care to Reduce Mortality of Preterm Infants in Migori County, Kenya and Busoga Region, Uganda","phase":"NA","overall_status":"COMPLETED","enrollment_count":102988,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT06263621","title":"Changing Portion Size Descriptions in a Cafeteria","phase":"NA","overall_status":"COMPLETED","enrollment_count":101481,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT03334760","title":"Breastfeeding and Complementary Feeding in Relation to BMI and Overweight","phase":"","overall_status":"COMPLETED","enrollment_count":100418,"lead_sponsor_name":"University Hospital Bispebjerg and Frederiksberg","has_results":false},{"nct_id":"NCT04182503","title":"Environmental Factors and Embryonic Development Project","phase":"","overall_status":"UNKNOWN","enrollment_count":100000,"lead_sponsor_name":"Jinling Hospital, China","has_results":false},{"nct_id":"NCT07514377","title":"JiGenerations Health Cohort Study：Parental Exposure and Intergenerational Health in China","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100000,"lead_sponsor_name":"National Research Institute for Family Planning, China","has_results":false},{"nct_id":"NCT07531134","title":"The Impact of Extreme Environmental and Security Conditions on Prematurity and Low Birth Weight Rates","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Hillel Yaffe Medical Center","has_results":false},{"nct_id":"NCT04907396","title":"International Weight Control Registry","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Tufts University","has_results":false},{"nct_id":"NCT03085875","title":"POWERMOM, A Healthy Pregnancy Research Community","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Scripps Translational Science Institute","has_results":false},{"nct_id":"NCT00063063","title":"Generic Database of Very Low Birth Weight Infants","phase":"","overall_status":"RECRUITING","enrollment_count":80000,"lead_sponsor_name":"NICHD Neonatal Research Network","has_results":false},{"nct_id":"NCT03677609","title":"Stanford Clinics Physician Mindset Training","phase":"NA","overall_status":"COMPLETED","enrollment_count":78128,"lead_sponsor_name":"Kari Alyse Leibowitz","has_results":false},{"nct_id":"NCT05530616","title":"Impact of Ultrasound Fetal Weight Estimation on Obstetrical Management and Maternal and Neonatal Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":70000,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT00009633","title":"Follow-up Visit of High Risk Infants","phase":"","overall_status":"RECRUITING","enrollment_count":68000,"lead_sponsor_name":"NICHD Neonatal Research Network","has_results":false},{"nct_id":"NCT03400696","title":"Web-based Weight Loss Intervention","phase":"NA","overall_status":"COMPLETED","enrollment_count":63656,"lead_sponsor_name":"23andMe, Inc.","has_results":false},{"nct_id":"NCT07417618","title":"INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60000,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT05484804","title":"Accountability for Care Through Undoing Racism & Equity for Moms","phase":"NA","overall_status":"RECRUITING","enrollment_count":60000,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT06874751","title":"Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real World","phase":"","overall_status":"COMPLETED","enrollment_count":45456,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT07048717","title":"The Mauritius and Rodrigues Non-Communicable Disease (NCD) Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":39082,"lead_sponsor_name":"Umeå University","has_results":false},{"nct_id":"NCT05087160","title":"Socioeconomic Inequalities Exacerbated by Mitigation Measures to COVID-19 and Differences in Prematurity Prevalence","phase":"","overall_status":"COMPLETED","enrollment_count":37323,"lead_sponsor_name":"Universidad de la Republica","has_results":false},{"nct_id":"NCT05121844","title":"Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":31187,"lead_sponsor_name":"Signos Inc","has_results":false},{"nct_id":"NCT03154177","title":"Group Antenatal/Postnatal Care in Rwanda","phase":"NA","overall_status":"COMPLETED","enrollment_count":26381,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT06653374","title":"Perinatal Conditions Influencing Morbidity, Mortality, and Medical Care in Newborns","phase":"","overall_status":"COMPLETED","enrollment_count":26000,"lead_sponsor_name":"HOSPITAL GINECO OBSTETRICO ISIDRO AYORA","has_results":false},{"nct_id":"NCT05708183","title":"Healthy Mums, Healthy Babies: Multiple Micronutrient Supplementation in Ethiopia","phase":"","overall_status":"RECRUITING","enrollment_count":25620,"lead_sponsor_name":"London School of Hygiene and Tropical Medicine","has_results":false},{"nct_id":"NCT05874635","title":"Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Signos Inc","has_results":false},{"nct_id":"NCT07059104","title":"Implant-based Breast Reconstruction in Post-bariatric Women - a Registry-based National Study","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Vastra Gotaland Region","has_results":false},{"nct_id":"NCT04042493","title":"Connect for Health Pediatric Weight Management Program","phase":"NA","overall_status":"COMPLETED","enrollment_count":19304,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT03574597","title":"Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":17604,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT07135115","title":"Targeting Lifestyle to Improve Colorectal Cancer Screening","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":16000,"lead_sponsor_name":"Norwegian Institute of Public Health","has_results":false},{"nct_id":"NCT02019264","title":"A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":14673,"lead_sponsor_name":"Eisai Inc.","has_results":true},{"nct_id":"NCT03281512","title":"Saturated Fatty Acids Intake and Mortality, Diabetes, Hypertension and Overweight","phase":"","overall_status":"COMPLETED","enrollment_count":14383,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT04113070","title":"Overweight and Obesity and Puberty Development Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":14100,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT07037433","title":"Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":12800,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT03261882","title":"Loss of a Healthy Weight Advantage Among Mexican-American Children","phase":"","overall_status":"COMPLETED","enrollment_count":11987,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false},{"nct_id":"NCT07430618","title":"Real-World Two-Year Weight Loss Outcomes With Breath Biofeedback","phase":"","overall_status":"COMPLETED","enrollment_count":11524,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT04827615","title":"Evaluation of the Ambuja Cement Foundation Noncommunicable Disease Program in Bathinda District of Punjab, India","phase":"NA","overall_status":"COMPLETED","enrollment_count":11322,"lead_sponsor_name":"Harvard School of Public Health (HSPH)","has_results":false},{"nct_id":"NCT05710913","title":"Development of Machine Learning Models for the Prediction of BMI and Complications After Bariatric Surgery (CABS-Study)","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Dr. Med Anas Taha","has_results":false},{"nct_id":"NCT05857319","title":"Study Consortium for Evaluation of RNPC Program in Obese and Overweight Patients (SCOOP-RNPC)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Groupe Éthique et Santé","has_results":false},{"nct_id":"NCT07448090","title":"Real-World Registry Study of Integrated Traditional Chinese and Western Medicine for Obesity","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Hubei Hospital of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT07336563","title":"ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Jarosław Drobnik","has_results":false},{"nct_id":"NCT03223363","title":"A New Birth Weight Prediction in Chinese Population","phase":"NA","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT04744714","title":"Gestational Weight Gain Criteria for Pregnant Women With Gestational Diabetes Mellitus in China","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Women's Hospital School Of Medicine Zhejiang University","has_results":false},{"nct_id":"NCT04494048","title":"Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry","phase":"","overall_status":"RECRUITING","enrollment_count":9999,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}